CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,854 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 14,343 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 4 Option exercise Director acquired 9,000 shares (option exercise)
- 4 Open-market sale CFO and Treasurer sold 15,000 shares at $21.15 ($317,250)
- 4 Open-market sale President and CEO sold 48,967 shares at $21.10 ($1,033,204)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Auditor change
Page 7 of 50 · 1,000 filings